Excel Physical Therapy, Llc - Medicare Physical Therapist in Jackson, WY

Excel Physical Therapy, Llc is a medicare enrolled "Physical Therapist" provider in Jackson, Wyoming. Their current practice location is 120 West Pearl Ave, Jackson, Wyoming. You can reach out to their office (for appointments etc.) via phone at (307) 734-9129.

Excel Physical Therapy, Llc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Excel Physical Therapy, Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1356414684.

Contact Information

Excel Physical Therapy, Llc
120 West Pearl Ave,
Jackson, WY 83002
(307) 734-9129
Not Available



Healthcare Provider's Profile

Full NameExcel Physical Therapy, Llc
TypeFacility
SpecialityPhysical Therapist
Location120 West Pearl Ave, Jackson, Wyoming
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1356414684
  • Provider Enumeration Date: 11/16/2006
  • Last Update Date: 09/05/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 0345242178
  • Enrollment ID: O20070208000079

Medical Identifiers

Medical identifiers for Excel Physical Therapy, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1356414684NPI-NPPES
123646600MedicaidWY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Excel Physical Therapy, Llc acts as a billing entity for following providers:
Provider NameFrancine P Bartlett
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1063468270
PECOS PAC ID: 9436154721
Enrollment ID: I20060920000043

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameMaria E Lofgren
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1285680041
PECOS PAC ID: 7618972720
Enrollment ID: I20060925000167

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameErin M Downey
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1124268552
PECOS PAC ID: 0749437499
Enrollment ID: I20120830000793

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameGianna M Risoli
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1811329410
PECOS PAC ID: 6002050994
Enrollment ID: I20130916000093

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameAriel Zablocki
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1295282556
PECOS PAC ID: 5698041408
Enrollment ID: I20171024000218

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameSarah J Niederbuhl
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1073963286
PECOS PAC ID: 4385930817
Enrollment ID: I20191114000862

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameCaitlin E Ciccone
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1255949905
PECOS PAC ID: 6507282589
Enrollment ID: I20200814001122

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameJoanna M Chadd
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1982193983
PECOS PAC ID: 2961757737
Enrollment ID: I20210604000557

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameKimberly M Micheletti
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1336628288
PECOS PAC ID: 5597008730
Enrollment ID: I20211101000334

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameMary Ann Mullane
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1053986430
PECOS PAC ID: 4880084318
Enrollment ID: I20211124000454

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameGina M La Tulipe
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1770566168
PECOS PAC ID: 2668483900
Enrollment ID: I20220110001315

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameKaitlin M Duffy
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1730657727
PECOS PAC ID: 7416340302
Enrollment ID: I20220217001952

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameTyler A Trumble
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1912517640
PECOS PAC ID: 5597131995
Enrollment ID: I20221025003287

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameJessie M Pearson
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1932820370
PECOS PAC ID: 9739535980
Enrollment ID: I20231025001332

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Provider NameKrysten G Williams
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1912681040
PECOS PAC ID: 8527414572
Enrollment ID: I20231026002465

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Excel Physical Therapy, Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Excel Physical Therapy, Llc
Po Box 8857,
Jackson, WY 83002-8857

Ph: (307) 734-2808
Excel Physical Therapy, Llc
120 West Pearl Ave,
Jackson, WY 83002

Ph: (307) 734-9129

News Archive

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing

French Ministry of Health approves cost-effectiveness study of RePneu Lung Volume Reduction Coil

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.

Research reveals TRPV3 protein as potential new drug target for cancer and skin disorders

New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.

Read more News

› Verified 2 days ago


Physical Therapist in Jackson, WY

Four Pines Physical Therapy Pc
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 1090 S Hwy 89, Jackson, WY 83001
Phone: 307-733-5577    Fax: 307-733-5505
Benjamin R Moore, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 555 East Broadway, Suite 100, Jackson, WY 83001
Phone: 307-739-7491    
Kara T Jordan, P.T.
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 120 W Pearl Ave, Jackson, WY 83001
Phone: 307-734-9129    Fax: 307-734-1427
Cossette Burnham, DPT, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: Four Pines Physical Therapy, 1090 S Hwy 89, Jackson, WY 83001
Phone: 307-733-5577    
Ms. Cassandra Ann Fuller, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 5310 South Park Drive, Suite 4, Jackson, WY 83002
Phone: 307-262-6372    Fax: 307-200-6403
Mary Ann Mullane, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 1090 S Hwy 89, Jackson, WY 83001
Phone: 307-733-5577    
Dr. Jacob Wayne Munger, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 1090 S Hwy 89, Jackson, WY 83001
Phone: 307-733-5577    Fax: 307-733-5505

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.